What is the best trade option for Convey Health Solutions Holdings Inc. (CNVY) stock?

At the time of writing, Convey Health Solutions Holdings Inc. [CNVY] stock is trading at $10.46, up saw in change for the day. An important factor to consider is whether the stock is rising or falling in short-term value. The CNVY shares have gain 0.10% over the last week, with a monthly amount glided 0.29%, and seem to be holding up well over a long-time horizon.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


On 21, June 2022, Convey To Be Taken Private By TPG. In a post published today on Yahoo Finance, Convey Shareholders to Receive $10.50 per Share in Cash, Representing a 99% Premium Over Convey’s 30-Day Volume Weighted Average Price.

From an analyst’s perspective:

Convey Health Solutions Holdings Inc. [NYSE: CNVY] stock has seen the most recent analyst activity on April 07, 2022, when Guggenheim initiated its Buy rating and assigned the stock a price target of $12. Previously, Goldman started tracking the stock with Neutral rating on February 11, 2022, and set its price target to $10. On July 12, 2021, Truist initiated with a Buy rating and assigned a price target of $16 on the stock. JP Morgan started tracking the stock assigning a Neutral rating and suggested a price target of $12 on July 12, 2021. Goldman initiated its recommendation with a Buy and recommended $21 as its price target on July 12, 2021. Canaccord Genuity started tracking with a Buy rating for this stock on July 12, 2021, and assigned it a price target of $18. In a note dated July 12, 2021, BofA Securities initiated an Buy rating and iterated a target price of $15 on this stock.

For the past year, the stock price of Convey Health Solutions Holdings Inc. fluctuated between $3.75 and $10.49. Currently, Wall Street analysts expect the stock to reach $10.83 within the next 12 months. Convey Health Solutions Holdings Inc. [NYSE: CNVY] shares were valued at $10.46 at the most recent close of the market. An investor can expect a potential return of 3.54% based on the average price forecast.

Analyzing the CNVY fundamentals

According to Convey Health Solutions Holdings Inc. [NYSE:CNVY], the company’s sales were 96.71 billion in the recent quarter, which represents an 17.10% jump. Gross Margin for this corporation currently stands at +33.12% with Operating Margin at +5.24%, Pretax Margin comes in at -3.14%, and Net Margin reading is -2.96%.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.44 points at the first support level, and at 10.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.47, and for the 2nd resistance point, it is at 10.48.

Convey Health Solutions Holdings Inc. [CNVY] reported earnings per share of -$0.02 for its fiscal quarter that ended on 3/30/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.01/share, meaning a difference of $-0.03 and a surprise factor of -300.00%. By comparison, the stated earnings for the previous quarter ended on 12/30/2021 were $0.01 per share as compared to estimates of $0.06 per share, a difference of $-0.05 representing a surprise of -83.30%.

Ratios To Look Out For

It is important to note that Convey Health Solutions Holdings Inc. [NYSE:CNVY] has a current ratio of 2.40. On the other hand, the Quick Ratio is 1.68, and the Cash Ratio is 0.55. Considering the valuation of this stock, the price to sales ratio is 1.81, the price to book ratio is 1.14.

Transactions by insiders

The next item on our agenda is insider trading, which has seen 0 insider purchases totaling 0 shares and 0 insider sales totaling 0 shares over the past 3 months.